Money Matters - Simplified

best stocks

GlaxoSmithKline Passes This Key Test

 There's no foolproof way to know the future for GlaxoSmithKline (NYSE: GSK) or any other company. However, certain clues may help you see potential stumbles before they happen -- and before your stock craters as a result. Rest assured: Even if you're not monitoring these metrics, short-sellers are.

 

Don't Get Too Worked Up Over Raytheon's Earnings


Although business headlines still tout earnings numbers, many investors have moved past net earnings as a measure of a company's economic output. That's because earnings are very often less trustworthy than cash flow, since earnings are more open to manipulation based on dubious judgment calls.

The Best Stocks for 2011: Yahoo!

 

This article is part of our "Best Stocks for 2011" series where our Foolish writers pick their top stock ideas for the year ahead. Click here to see a review of last year's picks and our 12 recommendations for the year ahead.




Is Orthovita Working Hard Enough for You?

 Margins matter. The more Orthovita (Nasdaq: VITA) keeps of each buck it earns in revenue, the more money it has to invest in growth, fund new strategic plans, or (gasp!) distribute to shareholders. Healthy margins often separate pretenders from the best stocks in the market. That's why I check on my holdings' margins at least once a quarter. I'm looking for the absolute numbers, comparisons to sector peers and competitors, and any trend that may tell me how strong Orthovita's competitive position could be.

 

Will FEI Disappoint Analysts Next Quarter?

There's no foolproof way to know the future for FEI (Nasdaq:FEIC) or any other company. However, certain clues may help you see potential stumbles before they happen -- and before your stock craters as a result. Rest assured: Even if you're not monitoring these metrics, short-sellers are.

 
 

Are These Software Companies Creating Value?

 "I think I've been in the top 5% of my age cohort all my life in understanding the power of incentives, and all my life I've underestimated it," Warren Buffett's business partner, Charlie Munger, once said. "And never a year passes but I get some surprise that pushes my limit a little farther."

 

Will Boeing Fumble Next Quarter?

 

There's no foolproof way to know the future for Boeing (NYSE: BA) or any other company. However, certain clues may help you see potential stumbles before they happen -- and before your stock craters as a result. Rest assured: Even if you're not monitoring these metrics, short-sellers are.




Should You Sell InterOil Right Now?

 Should you sell InterOil (NYSE: IOC) today? The decision to sell a stock you've researched and followed for months or years is never easy. But if you fall in love with your stock holdings, you risk becoming vulnerable to confirmation bias -- listening only to information that supports your theories, and rejecting any contradictions.

 

Check This to Find Out Whether Motorola Is Going to Bomb

 There's no foolproof way to know the future for Motorola (NYSE: MOT) or any other company. However, certain clues may help you see potential stumbles before they happen -- and before your stock craters as a result. Rest assured: Even if you're not monitoring these metrics, short-sellers are.

 

Don't Get Too Worked Up Over Gilead's Earnings

 
Although business headlines still tout earnings numbers, many investors have moved past net earnings as a measurement of a company's economic output. That's because earnings are very often less trustworthy than cash flow, since earnings are more open to manipulation based on dubious judgment calls.